1. Home
2. A-Z Publications
3. Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Current Drug Targets - Immune, Endocrine & Metabolic Disorders

ISSN: 1568-0088

Journal Status	Active

Latest Articles Lasest articles RSS feed

• • Boosting Interleukin-10 Production: Therapeutic Effects and Mechanisms

    Authors: Xiaoxia Zhou, Peter Schmidtke, Fred Zepp and Claudius U. Meyer

• • Signal Transducer and Activator of Transcription 5 (STAT5), a Crucial Regulator of Immune and Cancer Cells

    Authors: Ilka Wittig and Bernd Groner

• • Hormonal Effects on Drug Metabolism Through the CYP System: Perspectives on Their Potential Significance in the Era of Pharmacogenomics

    Authors: N. J. Sarlis and L. Gourgiotis

• • Insulin Regulation of PEPCK Gene Expression: A Model for Rapid and Reversible Modulation

    Authors: P. G. Quinn and D. Yeagley

• • Failure of Immune Homeostasis - The Consequences of Under and Over Reactivity

    Authors: B. Crimeen-Irwin, K. Scalzo, S. Gloster, P. L. Mottram and M. Plebanski

• • The New Immunosuppression: Intervention at the Dendritic Cell-T-Cell Interface

    Authors: A. M. Paterson, S. F. Yates, K. F. Nolan and H. Waldmann

• • Molecular Basis of Therapeutic Strategies for Breast Cancer

    Authors: Jing Huang, Xiaodong Li, Russell Hilf, Robert A. Bambara and Mesut Muyan

• • Management of Liver Disease in Thalassemia: Main Drug Targets for a Correct Therapy

    Authors: G. C. D. Vecchio, A. Nigro, P. Giordano and D. De Mattia

• • Augmenting T Helper Cell Immunity in Cancer

    Authors: K. L. Knutson and M. L. Disis

• • Amino Acid Transporter ATB0,+ as a Delivery System for Drugs and Prodrugs

    Authors: M. E. Ganapathy and V. Ganapathy
• More Less

Most Read This Month

Article

content/journals/cdtiemd

Journal

10

5

false

en